Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1993
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group
R Paridaens, J C Heuson, J P Julien, et al.
British Medical Journal
|
June 28, 1975
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study
J C Heuson, E Engelsman, J Blonk-Van Der Wijst, et al.
British Medical Journal
|
June 28, 1975
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study
E Engelsman, J C Heuson, J Blonk Van Der Wijst, et al.
European Journal of Cancer & Clinical Oncology
|
January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group
R Paridaens, H T Mouridsen, T Palshof, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: preliminary results of a double-blind randomized study of the EORTC Breast Cancer Cooperative Group
R Paridaens, J C Heuson, J P Julien, et al.
Cancer
|
December 15, 1988
Six-year results of a multimodality treatment strategy for locally advanced breast cancer
M J Piccart, D de Valeriola, R Paridaens, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1993
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group
R Paridaens, J C Heuson, J P Julien, et al.
British Medical Journal
|
June 28, 1975
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study
J C Heuson, E Engelsman, J Blonk-Van Der Wijst, et al.
British Medical Journal
|
June 28, 1975
Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study
E Engelsman, J C Heuson, J Blonk Van Der Wijst, et al.
European Journal of Cancer & Clinical Oncology
|
January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group
R Paridaens, H T Mouridsen, T Palshof, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: preliminary results of a double-blind randomized study of the EORTC Breast Cancer Cooperative Group
R Paridaens, J C Heuson, J P Julien, et al.
Cancer
|
December 15, 1988
Six-year results of a multimodality treatment strategy for locally advanced breast cancer
M J Piccart, D de Valeriola, R Paridaens, et al.
Page
of 4